Ankle-brachial index and peripheral arterial disease

Gesundheitswesen. 2005 Aug:67 Suppl 1:S57-61. doi: 10.1055/s-2005-858244.

Abstract

Patients with peripheral arterial disease including those with intermittent claudication have a high risk for cardiovascular and cerebrovascular morbidity and mortality. The outcome of patients with intermittent claudication is less limited by local complications in the leg than by the systemic complications of coronary and cerebral vessels. About 30 % of these patients will die within 5 years, three-quarters of them due to vascular events. Analyses using data of the KORA Study 2004/2005 (F3), a follow-up examination of the participants of the MONICA Survey 1994/95 (S3), will try to identify biochemical as well as genetic risk factors for peripheral arterial disease. The anti-atherogenic apolipoprotein A-IV will be one of our candidates of interest.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arteries*
  • Blood Pressure Determination / methods*
  • Blood Pressure Determination / statistics & numerical data
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / mortality*
  • Cohort Studies
  • Comorbidity
  • Female
  • Genetic Predisposition to Disease / epidemiology
  • Germany / epidemiology
  • Humans
  • Incidence
  • Internationality
  • Male
  • Middle Aged
  • Peripheral Vascular Diseases / diagnosis*
  • Peripheral Vascular Diseases / epidemiology*
  • Peripheral Vascular Diseases / genetics
  • Population Surveillance / methods
  • Registries*
  • Reproducibility of Results
  • Risk Assessment / methods*
  • Risk Factors
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Survival Analysis
  • World Health Organization